IG 26 Plus DF
Natural health product licensed in Canada
- Licence holder
- Xymogen
- NPN or DIN-HM
- 80097024
- Status
- Active licence
- Licence date
- 7 February 2020
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| D-Galacto-L-arabinane Source : Larix laricina-Bois | 1 g | Not calculated |
| Poudre d'oeuf séché Source : Gallus gallus - oeuf Potency : 1.8 g Egg Yolk Protein | 4.5 g | Not calculated |
Non-medicinal ingredients
Silice, Saveur, Extrait de fruit de monk
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1.5 Mesures | 1 Tous les jours |
Uses authorised in Canada
Provides a source of protein to support good health and to help build and repair body tissues.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Gastrointestinal disturbances have been known to occur; in which case discontinue use.
- Contre-indications
Individuals with egg allergies should not consume this product.
- Précautions et mises en garde
Consult your healthcare practitioner prior to use. Individuals taking medication should discuss potential interactions with their healthcare practitioner.
Source
Official Health Canada record, licence 80097024
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.